Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion

Children with X-linked hypophosphatemic rickets (XLH) are prone to progressive disproportionate stunting despite oral phosphate and vitamin D treatment.Our objective was to analyze the effects of GH treatment on stature and lengths of linear body segments in short children with XLH.A 3-yr randomized...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Živičnjak, Miro (VerfasserIn) , Schnabel, D. (VerfasserIn) , Staude, H. (VerfasserIn) , Even, G. (VerfasserIn) , Marx, M. (VerfasserIn) , Beetz, R. (VerfasserIn) , Holder, M. (VerfasserIn) , Billing, Heiko (VerfasserIn) , Fischer, D.-C. (VerfasserIn) , Rabl, W. (VerfasserIn) , Schumacher, M. (VerfasserIn) , Hiort, O. (VerfasserIn) , Haffner, Dieter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: October 12, 2011
In: The journal of clinical endocrinology & metabolism
Year: 2011, Jahrgang: 96, Heft: 12, Pages: E2097-E2105
ISSN:1945-7197
DOI:10.1210/jc.2011-0399
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1210/jc.2011-0399
Volltext
Verfasserangaben:M. Živičnjak, D. Schnabel, H. Staude, G. Even, M. Marx, R. Beetz, M. Holder, H. Billing, D.-C. Fischer, W. Rabl, M. Schumacher, O. Hiort, and D. Haffner, on behalf of the Hypophosphatemic Rickets Study Group of the Arbeitsgemeinschaft für Pädiatrische Endokrinologie and Gesellschaft für Pädiatrische Nephrologie

MARC

LEADER 00000caa a2200000 c 4500
001 1831772329
003 DE-627
005 20250414235845.0
007 cr uuu---uuuuu
008 230123s2011 xx |||||o 00| ||eng c
024 7 |a 10.1210/jc.2011-0399  |2 doi 
035 |a (DE-627)1831772329 
035 |a (DE-599)KXP1831772329 
035 |a (OCoLC)1389738254 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Živičnjak, Miro  |e VerfasserIn  |0 (DE-588)136129978  |0 (DE-627)575025808  |0 (DE-576)300849176  |4 aut 
245 1 0 |a Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets  |b effects on linear growth and body disproportion  |c M. Živičnjak, D. Schnabel, H. Staude, G. Even, M. Marx, R. Beetz, M. Holder, H. Billing, D.-C. Fischer, W. Rabl, M. Schumacher, O. Hiort, and D. Haffner, on behalf of the Hypophosphatemic Rickets Study Group of the Arbeitsgemeinschaft für Pädiatrische Endokrinologie and Gesellschaft für Pädiatrische Nephrologie 
264 1 |c October 12, 2011 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.01.2023 
520 |a Children with X-linked hypophosphatemic rickets (XLH) are prone to progressive disproportionate stunting despite oral phosphate and vitamin D treatment.Our objective was to analyze the effects of GH treatment on stature and lengths of linear body segments in short children with XLH.A 3-yr randomized controlled open-label GH study in short prepubertal children with XLH (n = 16) on phosphate and calcitriol treatment was conducted. A cohort of XLH patients (n = 76) on conservative treatment served as an XLH reference population.Changes in sd scores (SDS) of stature and linear body segments, i.e. sitting height, leg and arm length, and sitting height index (i.e. ratio between sitting height and stature) were the main outcome measures.XLH patients presented at time of enrollment with significant impairments of stature (−3.3 SDS) and linear body segments compared with healthy children. Leg length (−3.8 SDS) was most impaired, whereas sitting height (−1.7 SDS) was best preserved. The markedly elevated mean sitting height index (+3.3 SDS) reflected severe body disproportion. GH resulted in a sustained increase in linear growth (stature, +1.1 SDS; sitting height, +1.3 SDS; leg length, +0.8 SDS; arm length, +1.1 SDS; each P < 0.05 vs. baseline), whereas no significant changes were observed in controls. Mean height SDS at 3 yr did not significantly differ between groups. Sitting height index remained stable in both the GH-treated patients and in study controls but increased further in the XLH-reference population.The 3-yr GH treatment improved linear growth without progression of body disproportion in short children with XLH. 
700 1 |a Schnabel, D.  |e VerfasserIn  |4 aut 
700 1 |a Staude, H.  |e VerfasserIn  |4 aut 
700 1 |a Even, G.  |e VerfasserIn  |4 aut 
700 1 |a Marx, M.  |e VerfasserIn  |4 aut 
700 1 |a Beetz, R.  |e VerfasserIn  |4 aut 
700 1 |a Holder, M.  |e VerfasserIn  |4 aut 
700 1 |a Billing, Heiko  |d 1971-  |e VerfasserIn  |0 (DE-588)122639782  |0 (DE-627)70598138X  |0 (DE-576)293360057  |4 aut 
700 1 |a Fischer, D.-C.  |e VerfasserIn  |4 aut 
700 1 |a Rabl, W.  |e VerfasserIn  |4 aut 
700 1 |a Schumacher, M.  |e VerfasserIn  |4 aut 
700 1 |a Hiort, O.  |e VerfasserIn  |4 aut 
700 1 |8 1\p  |a Haffner, Dieter  |d 1963-  |e VerfasserIn  |0 (DE-588)132544237  |0 (DE-627)523362323  |0 (DE-576)299215040  |4 aut 
773 0 8 |i Enthalten in  |t The journal of clinical endocrinology & metabolism  |d Oxford : Oxford University Press, 1941  |g 96(2011), 12, Seite E2097-E2105  |h Online-Ressource  |w (DE-627)323606261  |w (DE-600)2026217-6  |w (DE-576)094425523  |x 1945-7197  |7 nnas  |a Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets effects on linear growth and body disproportion 
773 1 8 |g volume:96  |g year:2011  |g number:12  |g pages:E2097-E2105  |g extent:9  |a Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets effects on linear growth and body disproportion 
856 4 0 |u https://doi.org/10.1210/jc.2011-0399  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20250403  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20230123 
993 |a Article 
994 |a 2011 
998 |g 122639782  |a Billing, Heiko  |m 122639782:Billing, Heiko  |d 910000  |d 910500  |e 910000PB122639782  |e 910500PB122639782  |k 0/910000/  |k 1/910000/910500/  |p 8 
999 |a KXP-PPN1831772329  |e 4250624188 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1210/jc.2011-0399"],"eki":["1831772329"]},"title":[{"title":"Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets","title_sort":"Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets","subtitle":"effects on linear growth and body disproportion"}],"recId":"1831772329","note":["Gesehen am 23.01.2023"],"language":["eng"],"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"October 12, 2011"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"given":"Miro","display":"Živičnjak, Miro","role":"aut","roleDisplay":"VerfasserIn","family":"Živičnjak"},{"display":"Schnabel, D.","role":"aut","given":"D.","roleDisplay":"VerfasserIn","family":"Schnabel"},{"roleDisplay":"VerfasserIn","family":"Staude","role":"aut","display":"Staude, H.","given":"H."},{"given":"G.","display":"Even, G.","role":"aut","family":"Even","roleDisplay":"VerfasserIn"},{"family":"Marx","roleDisplay":"VerfasserIn","given":"M.","display":"Marx, M.","role":"aut"},{"family":"Beetz","roleDisplay":"VerfasserIn","given":"R.","display":"Beetz, R.","role":"aut"},{"display":"Holder, M.","role":"aut","given":"M.","roleDisplay":"VerfasserIn","family":"Holder"},{"role":"aut","display":"Billing, Heiko","given":"Heiko","family":"Billing","roleDisplay":"VerfasserIn"},{"given":"D.-C.","display":"Fischer, D.-C.","role":"aut","roleDisplay":"VerfasserIn","family":"Fischer"},{"family":"Rabl","roleDisplay":"VerfasserIn","given":"W.","display":"Rabl, W.","role":"aut"},{"family":"Schumacher","roleDisplay":"VerfasserIn","role":"aut","display":"Schumacher, M.","given":"M."},{"given":"O.","display":"Hiort, O.","role":"aut","roleDisplay":"VerfasserIn","family":"Hiort"},{"family":"Haffner","roleDisplay":"VerfasserIn","display":"Haffner, Dieter","role":"aut","given":"Dieter"}],"name":{"displayForm":["M. Živičnjak, D. Schnabel, H. Staude, G. Even, M. Marx, R. Beetz, M. Holder, H. Billing, D.-C. Fischer, W. Rabl, M. Schumacher, O. Hiort, and D. Haffner, on behalf of the Hypophosphatemic Rickets Study Group of the Arbeitsgemeinschaft für Pädiatrische Endokrinologie and Gesellschaft für Pädiatrische Nephrologie"]},"physDesc":[{"extent":"9 S."}],"relHost":[{"recId":"323606261","pubHistory":["1.1941 -"],"titleAlt":[{"title":"JCEM"},{"title":"The Journal of clinical endocrinology"}],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"Endocrine Society"}],"origin":[{"publisher":"Oxford University Press ; Endocrine Society","publisherPlace":"Oxford ; Bethesda, Md.","dateIssuedKey":"1941","dateIssuedDisp":"1941-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Endocrine Society"]},"part":{"text":"96(2011), 12, Seite E2097-E2105","issue":"12","volume":"96","extent":"9","year":"2011","pages":"E2097-E2105"},"id":{"zdb":["2026217-6"],"eki":["323606261"],"issn":["1945-7197"]},"title":[{"title_sort":"journal of clinical endocrinology & metabolism","title":"The journal of clinical endocrinology & metabolism","subtitle":"JCEM"}],"note":["Gesehen am 30.03.2017"],"disp":"Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets effects on linear growth and body disproportionThe journal of clinical endocrinology & metabolism"}]} 
SRT |a ZIVICNJAKMTHREEYEARG1220